Steve Vucic
Steve Vucic
Professor of Neurology, University of Sydney
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Amyotrophic lateral sclerosis
MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen, O Hardiman, ...
The lancet 377 (9769), 942-955, 2011
23772011
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
12632012
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ...
Nature genetics 45 (11), 1353, 2013
10152013
Controversies and priorities in amyotrophic lateral sclerosis
MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ...
The Lancet Neurology 12 (3), 310-322, 2013
5302013
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
S Vucic, GA Nicholson, MC Kiernan
Brain 131 (6), 1540-1550, 2008
3952008
Guillain-Barré syndrome: an update
S Vucic, MC Kiernan, DR Cornblath
Journal of clinical neuroscience 16 (6), 733-741, 2009
3652009
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018
2952018
Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease
S Vucic, MC Kiernan
Brain 129 (9), 2436-2446, 2006
2802006
Motor neuron dysfunction in frontotemporal dementia
JR Burrell, MC Kiernan, S Vucic, JR Hodges
Brain 134 (9), 2582-2594, 2011
2762011
Riluzole, neuroprotection and amyotrophic lateral sclerosis
BC Cheah, S Vucic, AV Krishnan, MC Kiernan
Current medicinal chemistry 17 (18), 1942-1959, 2010
2762010
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis
IP Blair, KL Williams, ST Warraich, JC Durnall, AD Thoeng, J Manavis, ...
Journal of Neurology, Neurosurgery & Psychiatry 81 (6), 639-645, 2010
2442010
Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
S Vucic, U Ziemann, A Eisen, M Hallett, MC Kiernan
Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1161-1170, 2013
2412013
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
S Ramanathan, K Prelog, EH Barnes, EM Tantsis, SW Reddel, ...
Multiple Sclerosis Journal 22 (4), 470-482, 2016
2232016
Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings
AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ...
Neurology 89 (11), 1117-1126, 2017
2072017
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
S Vucic, JD Rothstein, MC Kiernan
Trends in neurosciences 37 (8), 433-442, 2014
2052014
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
2032016
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ...
Neurology-Neuroimmunology Neuroinflammation 1 (4), 2014
1972014
Emerging therapies and challenges in spinal muscular atrophy
MA Farrar, SB Park, S Vucic, KA Carey, BJ Turner, TH Gillingwater, ...
Annals of neurology 81 (3), 355-368, 2017
1882017
Axonal excitability properties in amyotrophic lateral sclerosis
S Vucic, MC Kiernan
Clinical Neurophysiology 117 (7), 1458-1466, 2006
1872006
Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy
E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ...
Neurology 89 (11), 1107-1116, 2017
1662017
The system can't perform the operation now. Try again later.
Articles 1–20